OG2023SC

Novo drops oral GLP-1 analog to focus on next-gen Rybelsus
Fierce Biotech
Fri, 11/1/19 - 10:36 am
Novo Nordisk
diabetes
OG2023SC
Rybelsus
oral semaglutide